• G Gregory Raab and David H Parr.
• Raab & Associates, Inc., North Bethesda, MD 20852-4328, USA. greg.raab@raab-associates.com
• J Am Coll Radiol. 2006 Oct 1; 3 (10): 772-7.

AbstractThis paper, the second of 3 that discuss the reimbursement challenges facing new medical device technology in various issues of this journal, explains the key aspects of coverage that affect the adoption of medical devices. The process Medicare uses to make coverage determinations has become more timely and open over the past several years, but it still lacks the predictability that product innovators prefer. The continued uncertainty surrounding evidence requirements undermines the predictability needed for optimal product planning and innovation. Recent steps taken by the Centers for Medicare and Medicaid Services to provide coverage in return for evidence development should provide patients with access to promising new technologies and procedures while generating important evidence concerning their effectiveness.

14 keywords...

hide…